Advertisement
Advertisement

ACET

ACET logo

Adicet Bio, Inc. Common Stock

7.95
USD
Sponsored
-0.55
-6.47%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

7.92

-0.04
-0.44%

ACET Earnings Reports

Positive Surprise Ratio

ACET beat 16 of 32 last estimates.

50%

Next Report

Date of Next Report
Mar 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.85
Implied change from Q3 25 (Revenue/ EPS)
--
/
-38.44%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+790.63%

Adicet Bio, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, ACET reported earnings of -4.63 USD per share (EPS) for Q3 25, beating the estimate of -4.72 USD, resulting in a 1.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of -2.85 USD, with revenue projected to reach -- USD, implying an decrease of -38.44% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Adicet Bio, Inc. Common Stock reported EPS of -$4.63, beating estimates by 1.86%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.91%, changed from $11.04 before the earnings release to $10.83 the day after.
The next earning report is scheduled for Mar 04, 2026.
Based on 9 analysts, Adicet Bio, Inc. Common Stock is expected to report EPS of -$2.85 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement